pretickt

Is CLX a good stock to buy?

The Clorox Company · end-of-day data as of Nov 13, 2026

Clorox
CLX · $13.24B
$109.46+1.2%
Nov 13, 2026 · close
$80$100SepOctNov9:3016:003 months +5.2%Nov 13 · close
▲ 6
  • P/E vs sector-11.1%
  • Insiders$400K
  • MAs4 of 4
  • MA20×50Golden 6d ago
  • MACD1.95
  • Sector▲ +6.0%
Neutral
  • Earnings in81d
  • P/E19.7x
  • Support-4.5%
  • Resistance+2.0%
  • Off 52w high-15.1%
  • Volume0.9x
  • Bollingerupper half
  • FCF yield+3.4%
  • ConsensusHold · 20
  • Trendsideways
  • 52w range$79–$129
  • ATR+3.3%
  • Off ATH-54.4%
▼ 4
  • PT$95.80 -12.5%
  • P/E vs own+16.5%
  • News
  • RSI84

Updates with the 15-min delayed price. Not a forecast or investment advice.

Is Clorox a good stock to buy?

Clorox is strong on 1 of the 5 questions about the business; weak on demand. The price is about usual: 19.7 times its earnings, near its 3-year median of 23.2 (Nov 13, 2026). pretickt does not say whether to buy or sell.

  1. Demand shrinking
  2. Advantage some edge
  3. Economics very profitable
  4. Execution mixed
  5. Fragility some risks
  6. Price about usual
DemandDo people want more of what it sells?shrinking

CLX sales growth revenue growth

-3%a year, for the last 3 years

Clorox's sales fell 3% a year for 3 years, to $6.72B in fiscal 2026.

CLX analysts' forecast revenue estimates

+14%the sales they expect next fiscal year, on the last

Analysts expect Clorox's sales to grow 14% to $7.64B in fiscal 2027 (12 analysts).

CLX competitors

pretickt analysis+6%its sales in 12 months, on a year before

Clorox's sales grew 6% in the 12 months to Sep 30, 2026, faster than Colgate-Palmolive (+6%), Estée Lauder (+6%), Church & Dwight (+2%) and Kimberly-Clark (-8%).

CLX sales by business revenue by segment

40%of its sales from Health and Wellness

Health and Wellness brought Clorox 40% of its sales in fiscal 2026; Household 27%.

Advantage moatIs it hard to copy?some edge

CLX return on capital ROIC

pretickt analysis37%earned before tax on the money invested in it

Clorox earned 37% before tax on the capital invested in it in the 12 months to Sep 30, 2026; Colgate-Palmolive 67%, Kimberly-Clark 27%, Estée Lauder 20% and Church & Dwight 18%.

CLX margin on each sale gross margin

42%left after making the product

Clorox kept 42% of each sale after making the product in the 12 months to Sep 30, 2026; its competitors' median is 53%.

EconomicsDoes it make good money?very profitable

CLX margin after costs profit margin

28%of sales left after running the business

Clorox's operating margin was 28% in the 12 months to Sep 30, 2026, against 11% in fiscal 2023.

CLX cash generated free cash flow

$453Mcash left after investing, last 12 months

Clorox generated $453M of free cash flow in the 12 months to Sep 30, 2026, less than its reported profit.

CLX profit per share

-26%in its last fiscal year

Clorox's earnings per share fell 26% in fiscal 2026, to $4.81.

ExecutionDoes it deliver what it promises?mixed

CLX earnings vs estimates

6 of 8quarters above the analysts' estimate

Clorox beat the analysts' profit estimate in 6 of its last 8 quarters, the latest on Nov 2, 2026.

CLX insider buying

+$1.25Mbought, net, by its executives in 12 months

Clorox's executives and directors bought a net $1.25M of shares in the 12 months to Nov 13, 2026; none sold.

CLX number of employees

+21%more people in a year

Clorox had 9,200 employees at the end of fiscal 2026, 21% more than a year before.

CLX CEO pay

$14Mfor fiscal 2026, 76% of it in stock and options

Clorox paid its CEO $14M for fiscal 2026, 76% of it in stock and options.

Fragility risksCould something break it?some risks

CLX financial health Altman Z-score

2.3Altman Z-score, safe above 3

Clorox's Altman Z-score is 2.3 (Nov 13, 2026), between 1.8 and 3, the grey zone.

CLX quality checks Piotroski score

3 of 9checks passed

Clorox passes 3 of the 9 Piotroski checks in the 12 months to Sep 30, 2026; it misses on return on assets, cash against profit, long-term debt, the current ratio, gross margin and sales for its assets.

CLX biggest customers

26%of sales from its biggest customer

Walmart made 26% of Clorox's sales in fiscal 2026.

CLX shareholders institutional ownership

pretickt analysis
  • Vanguard11.2% ▲
  • BlackRock8.2% ▼
  • State Street6.9% ▲
1,104institutions hold it; the largest added shares

1,104 institutions hold 87% of Clorox's shares (Jun 30, 2026); Vanguard and State Street added shares that quarter, BlackRock sold some.

CLX in past recessions

pretickt analysis+3%its sales in the worst one

Clorox's sales grew through each of the last 2 US recessions (2008–09 and 2020).

Price valuationIs the price reasonable?about usual

CLX price vs profit P/E ratio

19.7×a year's earnings

Clorox's P/E ratio is 19.7 (Nov 13, 2026), near its 3-year median of 23.2.

CLX price vs competitors

pretickt analysis19.7×a year's earnings, against its competitors

Investors pay 19.7 times Clorox's earnings (Nov 13, 2026), more than for Kimberly-Clark (11.0), less than for Estée Lauder (111.8), Colgate-Palmolive (39.0) and Church & Dwight (34.8).

CLX analysts' target price target

-12%to their average target

Analysts' average price target for Clorox is $95.80, 12% below the Nov 13, 2026 close of $109.46.

CLX analyst ratings, 90 days

pretickt analysis
  • Evercore ISI Groupupgrade
1 up, 0 downratings raised and cut

In the 90 days to Nov 13, 2026, Evercore ISI Group upgraded Clorox.

CLX growth priced in fair value

pretickt analysis+12%a year, for ten years, to be worth the price

At $109.46 a share, Clorox's free cash flow must grow about 12% a year for ten years to be worth the price (Nov 13, 2026).

What is Clorox's P/E ratio?

Clorox's P/E ratio is 19.7 (Nov 13, 2026), near its 3-year median of 23.2. Investors pay 19.7 times Clorox's earnings (Nov 13, 2026), more than for Kimberly-Clark (11.0), less than for Estée Lauder (111.8), Colgate-Palmolive (39.0) and Church & Dwight (34.8).

Who are Clorox's biggest competitors?

pretickt compares Clorox with Church & Dwight, Kimberly-Clark, Estée Lauder and Colgate-Palmolive. Clorox's sales grew 6% in the 12 months to Sep 30, 2026, faster than Colgate-Palmolive (+6%), Estée Lauder (+6%), Church & Dwight (+2%) and Kimberly-Clark (-8%).

Is Clorox profitable?

Clorox's operating margin was 28% in the 12 months to Sep 30, 2026, against 11% in fiscal 2023. Clorox generated $453M of free cash flow in the 12 months to Sep 30, 2026, less than its reported profit.

Are insiders buying Clorox stock?

Clorox's executives and directors bought a net $1.25M of shares in the 12 months to Nov 13, 2026; none sold.

How does Clorox make money?

Health and Wellness brought Clorox 40% of its sales in fiscal 2026; Household 27%.

Who owns Clorox stock?

1,104 institutions hold 87% of Clorox's shares (Jun 30, 2026); Vanguard and State Street added shares that quarter, BlackRock sold some.

How many employees does Clorox have?

Clorox had 9,200 employees at the end of fiscal 2026, 21% more than a year before.

Who are Clorox's biggest customers?

Walmart made 26% of Clorox's sales in fiscal 2026.

From the companies' statements (FMP), their filings read by pretickt, the analysts and the insiders, as of Nov 13, 2026. Each card says what a fact means for its question, never what to do with the stock: for information only, not investment advice.